View Press Release Form

BoomRx, the fastest-growing national pharmaceutical technology platform that simplifies prescription sourcing and fulfillment, today announced the availability of oral semaglutide and tirzepatide options utilizing advanced nanoemulsion delivery for medical clinics, med spas, wellness practices, and telemedicine providers nationwide. The newly introduced formulations apply nanoemulsion technology to convert each dose into microscopic particles, supporting more uniform dispersion and enhanced absorption. This injection-free delivery option offers healthcare providers greater flexibility and consistency as weight-management programs continue to evolve into long-term, scalable care models. “Semaglutide and tirzepatide have become foundational therapies in weight management, and how they’re delivered matters,” said Kurt Lunkwitz, founder …